Retraction of: HOXD-AS1 Exerts Oncogenic Functions and Promotes Chemoresistance in Cisplatin-Resistant Cervical Cancer Cells by Chi et al. (doi: 10.1089/hum.2017.256)
- PMID: 35353631
- PMCID: PMC9142764
- DOI: 10.1089/hum.2017.256.retract
Retraction of: HOXD-AS1 Exerts Oncogenic Functions and Promotes Chemoresistance in Cisplatin-Resistant Cervical Cancer Cells by Chi et al. (doi: 10.1089/hum.2017.256)
Retraction of
-
HOXD-AS1 Exerts Oncogenic Functions and Promotes Chemoresistance in Cisplatin-Resistant Cervical Cancer Cells.Hum Gene Ther. 2018 Dec;29(12):1438-1448. doi: 10.1089/hum.2017.256. Epub 2018 Sep 5. Hum Gene Ther. 2018. Retraction in: Hum Gene Ther. 2022 May;33(9-10):572. doi: 10.1089/hum.2017.256.retract. PMID: 29896986 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources